Charles Cherington - 16 Jun 2021 Form 4 Insider Report for Brooklyn ImmunoTherapeutics, Inc. (ERNA)

Role
Director, 10%+ Owner
Signature
/s/ Mark L. Johnson, Attorney-in-Fact for Charles Cherington
Issuer symbol
ERNA
Transactions as of
16 Jun 2021
Transactions value $
-$6,296,568
Form type
4
Filing time
21 Jun 2021, 18:00:24 UTC
Next filing
23 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ERNA Common Stock Sale -$3.15M -200K -3.18% $15.73* 6.09M 16 Jun 2021 Direct F1
transaction ERNA Common Stock Sale -$3.12M -198K -3.25% $15.74* 5.9M 17 Jun 2021 Direct F2
transaction ERNA Common Stock Sale -$32.6K -2K -0.03% $16.30* 5.89M 17 Jun 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.53 to $16.11, inclusive.
F2 The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.25 to $16.24, inclusive.
F3 The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.25 to $16.35, inclusive.

Remarks:

The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 through 3 to this Form 4.